Peter Leif Bergsagel (P L Bergsagel, P Leif Bergsagel, Matteo Bergsagel, P Leif Bergsagel, Leif Bergsagel, Marco Bergsagel)

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 55

Top Topics

Acute Lymphoblastic Leukemia

Multiple Myeloma

Top Venues

Blood cancer journal

Blood cancer discovery

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Francesco Maura, David G Coffey, Caleb K Stein, Esteban Braggio, Bachisio Ziccheddu, Meaghen E Sharik, Megan Du, Yuliza Tofaya Alvarado, Chang-Xin Shi, Yuan Xiao Zhu, Erin W Meermeier, Gareth J Morgan, Carl Ola Landgren, Peter Leif Bergsagel, Marta Chesi
The Vk*MYC Mouse Model recapitulates human multiple myeloma evolution and genomic diversity. bioRxiv : the preprint server for biology (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Udit Yadav, Shaji K Kumar, Linda B Baughn, Angela Dispenzieri, Patricia T Greipp, Rhett P Ketterling, Dragan Jevremovic, Francis K Buadi, David Dingli, Martha Q Lacy, Rafael Fonseca, Peter Leif Bergsagel, Sikander Ailawadhi, Vivek Roy, Ricardo D Parrondo, Taimur Sher, Suzanne R Hayman, Prashant Kapoor, Nelson R Leung, Joselle M Cook, Moritz Binder, Eli Muchtar, Rahma M Warsame, Taxiarchis V Kourelis, Ronald S Go, Yi Lin, Abhishek Seth, Scott C Lester, William G Breen, Robert A Kyle, Morie A Gertz, S Vincent Rajkumar, Wilson I Gonsalves
Impact of Cytogenetic Abnormalities on the Risk of Disease Progression in Solitary Bone Plasmacytomas. Blood (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Sundararajan Vincent Rajkumar, Nadine H Abdallah, Arjun Lakshman, Shaji K Kumar, Joselle M Cook, Moritz Binder, Prashant Kapoor, Angela Dispenzieri, Morie A Gertz, Martha Lacy, Suzanne Hayman, Francis K Buadi, David Dingli, Yi Lin, Taxiarchis V Kourelis, Rahma Warsame, Peter Leif Bergsagel
Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patients. Research square (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Paola Neri, Benjamin G Barwick, David Jung, Jonathan C Patton, Ranjan Maity, Ines Tagoug, Caleb K Stein, Rémi Tilmont, Noemie Leblay, Sungwoo Ahn, Holly Lee, Seth J Welsh, Daniel L Riggs, Nicholas Stong, Erin Flynt, Anjan Thakurta, Jonathan J Keats, Sagar Lonial, Peter Leif Bergsagel, Lawrence H Boise, Nizar J Bahlis
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma. Blood cancer discovery (2023)
Seth J Welsh, Benjamin G Barwick, Erin W Meermeier, Daniel L Riggs, Chang-Xin Shi, Yuan Xiao Zhu, Meaghen E Sharik, Megan T Du, Leslie D Abrego Rocha, Victoria M Garbitt, Caleb K Stein, Joachim L Petit, Nathalie Meurice, Yuliza Tafoya Alvarado, Rodrigo Fonseca, Kennedi T Todd, Sochilt Brown, Zachary J Hammond, Nicklus H Cuc, Courtney Wittenberg, Camille Herzog, Anna V Roschke, Yulia N Demchenko, Wei-Dong D Chen, Peng Li, Wei Liao, Warren J Leonard, Sagar Lonial, Nizar J Bahlis, Paola Neri, Lawrence H Boise, Marta Chesi, Peter Leif Bergsagel
Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma. Blood cancer discovery (2023)
Linda B Baughn, Erik Jessen, Neeraj Sharma, Hongwei Tang, James B Smadbeck, Mark D Long, Kathryn Pearce, Matthew Smith, Surendra Dasari, Zohar Sachs, Michael A Linden, Joselle M Cook, A Keith Stewart, Marta Chesi, Amit Kumar Mitra, Peter Leif Bergsagel, Brian G Van Ness, Shaji K Kumar
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma. Blood cancer journal 13 (1) (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Radhika Bansal, Mizba Baksh, Jeremy T Larsen, Matthew A Hathcock, David Dingli, A Keith Stewart, Prashant Kapoor, Taxiarchis V Kourelis, Suzanne R Hayman, Rahma M Warsame, Rafael Fonseca, Peter Leif Bergsagel, Sikander Ailawadhi, Shaji K Kumar, Yi Lin
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma. Blood cancer journal 13 (1) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, Craig B Reeder, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood cancer journal 13 (1) (2023)
Julia Erin Wiedmeier-Nutor, Peter Leif Bergsagel
Review of Multiple Myeloma Genetics including Effects on Prognosis, Response to Treatment, and Diagnostic Workup. Life (Basel, Switzerland) 12 (6) (2022)
Laurence de Leval, Ash A Alizadeh, Peter Leif Bergsagel, Elias Campo, Andrew John Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M Horwitz, Ari M Melnick, William George Morice, Ryan D Morin, Bertrand Nadel, Stefano A Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P Treon, Andrew D Zelenetz, Ranjana H Advani, Carl E Allen, Stephen M Ansell, Wing C John Chan, James R Cook, Lucy B M Cook, Francesco d'Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G Gribben, Olivier Hermine, Daniel James Hodson, Eric D Hsi, Giorgio Ga Inghirami, Elaine S Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L King, Young-Hyeh Ko, Ann Steward LaCasce, Georg Lenz, José I Martin-Subero, Miguel Angel Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Martínez, Scott J Rodig, Andreas Rosenwald, Gilles Andre Salles, Jesús San F Miguel, Kerry J Savage, Laurie Helen Sehn, Gianpietro C Semenzato, Louis M Staudt, Steven Howard Swerdlow, Constantine S Tam, Judith Trotman, Julie M Vose, Oliver Weigert, Wyndham H Wilson, Jane N Winter, Catherine J Wu, Pier Luigi Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W Scott
Genomic profiling for clinical decision making in lymphoid neoplasms. Blood 140 (21) (2022)
Faith E Davies, Charlotte Pawlyn, Saad Z Usmani, Jesús San F Miguel, Hermann Einsele, Eileen Mary Boyle, Jill Corre, Daniel Auclair, Hearn Jay Cho, Sagar Lonial, Pieter Sonneveld, A Keith Stewart, Peter Leif Bergsagel, Martin F Kaiser, Katja Weisel, Jonathan J Keats, Joseph R Mikhael, Kathryn E Morgan, Irene M Ghobrial, Robert Z Orlowski, Carl Ola Landgren, Francesca Gay, Joseph Caers, Wee-Joo Chng, Ajai Chari, Brian A Walker, Shaji K Kumar, Luciano José Megale Costa, Kenneth C Anderson, Gareth J Morgan
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma. Blood cancer discovery 3 (4) (2022)
Marie-France Gagnon, Shulan Tian, Susan Geyer, Neeraj Sharma, Celine M Vachon, Yael Kusne, Peter Leif Bergsagel, A Keith Stewart, Sundararajan Vincent Rajkumar, Shaji K Kumar, Sikander Ailawadhi, Linda B Baughn
Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms. Blood cancer journal 12 (7) (2022)
Nadine H Abdallah, Moritz Binder, Sundararajan Vincent Rajkumar, Patricia T Greipp, Prashant Kapoor, Angela Dispenzieri, Morie A Gertz, Linda B Baughn, Martha Q Lacy, Suzanne R Hayman, Francis K Buadi, David Dingli, Ronald S Go, Yi L Hwa, Amie L Fonder, Miriam A Hobbs, Yi Lin, Nelson Leung, Taxiarchis V Kourelis, Rahma Warsame, Mustaqeem A Siddiqui, Robert A Kyle, Peter Leif Bergsagel, Rafael Fonseca, Rhett P Ketterling, Shaji K Kumar
A simple additive staging system for newly diagnosed multiple myeloma. Blood cancer journal 12 (1) (2022)
Ricardo D Parrondo, Zaid Abdel Rahman, Michael G Heckman, Mikolaj Wieczorek, Liuyan Jiang, Hassan B Alkhateeb, Mark R Litzow, Patricia Greipp, Taimur Sher, Peter Leif Bergsagel, Rafael Fonseca, Vivek Roy, Angela Dispenzieri, Mohamed A Kharfan-Dabaja, Hemant S Murthy, Sikander Ailawadhi, James M Foran
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma. Blood cancer journal 12 (6) (2022)
Joselle Cook, Kah-Whye Peng, Thomas E Witzig, Stephen M Broski, Jose C Villasboas Bisneto, Jonas Paludo, Mirinal S Patnaik, Vincent Rajkumar, Angela Dispenzieri, Nelson R Leung, Francis K Buadi, N Nora Bennani, Stephen M Ansell, Lianwen Zhang, Nandakumar Packiriswamy, Baskar Balakrishnan, Bethany Brunton, Marissa Giers, Brenda Ginos, Amylou C Dueck, Susan Geyer, Morie A Gertz, Rahma M Warsame, Ronald S Go, Suzanne R Hayman, David Dingli, Shaji K Kumar, Peter Leif Bergsagel, Javier L Munoz, Wilson Gonsalves, Taxiarchis V Kourelis, Eli Muchtar, Prashant Kapoor, Robert A Kyle, Yi Lin, Mustaqeem A Siddiqui, Amie L Fonder, Miriam Hobbs, Lisa Hwa, Shruthi Naik, Stephen J Russell, Martha Q Lacy
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma. Blood advances 6 (11) (2022)
Elias Campo, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Martínez, Steven H Swerdlow, Kenneth C Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Dogan, Andrew L Feldman, Falko Fend, Jonathan W Friedberg, Philippe Gaulard, Paolo Ghia, Steven M Horwitz, Rebecca L King, Gilles Andre Salles, Jesús San F Miguel, John Francis Seymour, Steven P Treon, Julie M Vose, Emanuele Zucca, Ranjana Advani, Stephen Ansell, Wing-Yan Au, Carlos Barrionuevo, Peter Leif Bergsagel, Wing C Chan, Jeffrey I Cohen, Francesco d'Amore, Andrew John Davies, Brunangelo Falini, Irene M Ghobrial, Mariusz A Wasik, John G Gribben, Eric D Hsi, Brad S Kahl, Won-Seog Kim, Shaji K Kumar, Ann Steward LaCasce, Camille Laurent, Georg Lenz, John P Leonard, Michael P Link, Armando Lopez-Guillermo, Maria-Victoria Mateos-Manteca, Elizabeth A Macintyre, Ari M Melnick, Judith Trotman, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano A Pileri, Miguel Angel Piris, Barbara Pro, Vincent Rajkumar, Steven T Rosen, Birgitta Sander, Laurie Sehn, Margaret A Shipp, Sonali M Smith, Louis M Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H Wilson, Tadashi Yoshino, Pier Luigi Luigi Zinzani, Martin Dreyling, David W Scott, Jane N Winter, Andrew D Zelenetz
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140 (11) (2022)
R Leo Sakemura, Mehrdad Hefazi, Elizabeth L Siegler, Michelle J Cox, Daniel P Larson, Michael J Hansen, Claudia Manriquez Roman, Kendall J Schick, Ismail Can, Erin E Tapper, Paulina Horvei, Mohamad M Adada, Evandro D Bezerra, Lionel Aurelien A Kankeu Fonkoua, Michael W Ruff, Wendy K Nevala, Denise K Walters, Sameer A Parikh, Yi Lin, Diane F Jelinek, Neil E Kay, Peter Leif Bergsagel, Saad S Kenderian
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma. Blood 139 (26) (2022)
Mark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis, Robert A Redd, Eileen Mary Boyle, Benny Zhitomirsky, Andrew J Dunford, Yu-Tzu Tai, Selina J Chavda, Cody Boehner, Carl Jannes Neuse, Mahshid Rahmat, Andrew T Hutchinson, Tineke Casneuf, Raluca Verona, Efstathis Kastritis, Lorenzo Trippa, Chip Stewart, Brian A Walker, Faith E Davies, Meletios- Athanasios Dimopoulos, Peter Leif Bergsagel, Kwee L Yong, Gareth J Morgan, François Aguet, Gad A Getz, Irene M Ghobrial
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes. Nature communications 13 (1) (2022)
Eli Muchtar, Morie A Gertz, Betsy R LaPlant, Francis K Buadi, Nelson R Leung, Patrick O'Brien, Peter Leif Bergsagel, Amie L Fonder, Yi Lisa Hwa, Miriam Hobbs, Dania K Helgeson, Erin E Bradt, Wilson Gonsalves, Martha Q Lacy, Prashant Kapoor, Mustaqeem A Siddiqui, Jeremy T Larsen, Rahma M Warsame, Suzanne R Hayman, Ronald S Go, David Dingli, Taxiarchis V Kourelis, Angela Dispenzieri, S Vincent Rajkumar, Shaji K Kumar
Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis. Blood advances 6 (18) (2022)
Josh N Vo, Yi-Mi Wu, Jeanmarie Mishler, Sarah Hall, Rahul Mannan, Lisha Wang, Yu Ning, Jin Zhou, Alexander C Hopkins, James C Estill, Wallace K B Chan, Jennifer Yesil, Xuhong Cao, Arvind Rao, Alexander Tsodikov, Moshe Talpaz, Craig E Cole, Jing C Ye, null null, Peter Leif Bergsagel, Daniel Auclair, Hearn Jay Cho, Dan R Robinson, Arul M Chinnaiyan
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma. Nature communications 13 (1) (2022)
Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Peter Leif Bergsagel, Moritz Binder, Asher A Chanan-Khan, David Dingli, Angela Dispenzieri, Rafael Fonseca, Morie A Gertz, Wilson Gonsalves, Ronald S Go, Suzanne Hayman, Prashant Kapoor, Taxiarchis V Kourelis, Martha Q Lacy, Nelson R Leung, Yi Lin, Eli Muchtar, Vivek Roy, Taimur Sher, Rahma M Warsame, Amie L Fonder, Miriam Hobbs, Yi L Hwa, Robert A Kyle, S Vincent Rajkumar, Shaji K Kumar
Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance. Blood 140 (18) (2022)
Erin W Meermeier, Seth J Welsh, Meaghen E Sharik, Megan T Du, Victoria M Garbitt, Daniel L Riggs, Chang-Xin Shi, Caleb K Stein, Peter Leif Bergsagel, Bryant Chau, Matthew L Wheeler, Natalie Bezman, Feng Wang, Pavel Strop, Marta Chesi
Tumor burden limits bispecific antibody efficacy through T cell exhaustion averted by concurrent cytotoxic therapy. Blood cancer discovery 2 (4) (2022)
Marta Chesi, Caleb K Stein, Victoria M Garbitt, Meaghen E Sharik, Yan W Asmann, Peter Leif Bergsagel, Daniel L Riggs, Seth J Welsh, Erin W Meermeier, Shaji K Kumar, Esteban Braggio
Monosomic loss of MIR15A/MIR16-1 is a driver of multiple myeloma proliferation and disease progression. Blood cancer discovery 1 (1) (2022)
Saurabh Zanwar, Matthew Ho, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Peter Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Rafael Fonseca, Morie A Gertz, Wilson Gonsalves, Ronald S Go, Suzanne Hayman, Prashant Kapoor, Taxiarchis V Kourelis, Martha Q Lacy, Nelson Leung, Yi Lin, Eli Muchtar, Vivek Roy, Taimur Sher, Rahma Warsame, Amie Fonder, Miriam Hobbs, Yi L Hwa, Robert A Kyle, Sundararajan Vincent Rajkumar, Shaji K Kumar
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy. Blood cancer journal 12 (11) (2022)
Neeraj Sharma, James B Smadbeck, Nadine H Abdallah, Cinthya Zepeda-Mendoza, Moritz Binder, Kathryn E Pearce, Yan W Asmann, Jess F Peterson, Rhett P Ketterling, Patricia T Greipp, Peter Leif Bergsagel, S Vincent Rajkumar, Shaji K Kumar, Linda B Baughn
The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Danielle C Croucher, Laura M Richards, Serges P Tsofack, Daniel D Waller, Zhihua Li, Ellen Nong Wei, Xian Fang Huang, Marta Chesi, Peter Leif Bergsagel, Michael Sebag, Trevor J Pugh, Suzanne Trudel
Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression. Nature communications 12 (1) (2021)
Yan W Asmann, Kaushal Parikh, Peter Leif Bergsagel, Haidong Dong, Alex A Adjei, Mitesh J Borad, Aaron S Mansfield
Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups. NPJ precision oncology 5 (1) (2021)
Nadine H Abdallah, Linda B Baughn, S Vincent Rajkumar, Prashant Kapoor, Morie A Gertz, Angela Dispenzieri, Martha Q Lacy, Suzanne R Hayman, Francis K Buadi, David Dingli, Ronald S Go, Yi L Hwa, Amie Fonder, Miriam Hobbs, Yi Lin, Nelson Leung, Taxiarchis Kourelis, Rahma Warsame, Mustaqeem Siddiqui, John Lust, Robert A Kyle, Rhett Ketterling, Peter Leif Bergsagel, Patricia Greipp, Shaji K Kumar
Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (24) (2020)
Linda B Baughn, Zhuo Li, Kathryn Pearce, Celine M Vachon, Mei-Yin Polley, Jonathan J Keats, Eran Elhaik, Michael Baird, Terry Therneau, James R Cerhan, Peter Leif Bergsagel, Angela Dispenzieri, Sundararajan Vincent Rajkumar, Yan W Asmann, Shaji K Kumar
The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias. Blood cancer journal 10 (3) (2020)
Huan Liu, Jin He, Su Pin Koh, Yuping Zhong, Zhiqiang Liu, Zhiqiang Wang, Yujin Zhang, Zongwei Li, Bjorn T Tam, Pei Lin, Min Xiao, Ken H Young, Behrang Amini, Michael W Starbuck, Hans C Lee, Nora M Navone, Richard Eric Davis, Qiang Tong, Peter Leif Bergsagel, Jian Hou, Qing Yi, Robert Z Orlowski, Robert F Gagel, Jing Yang
Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease. Science translational medicine 11 (494) (2020)
Chandini M Thirukkumaran, Zhong Qiao Shi, Gerard J Nuovo, Joanne Luider, Karen A Kopciuk, Yuan Dong, Ahmed A Mostafa, Satbir Thakur, Kathy Gratton, Ailian Yang, Alex C Chin, Matt C Coffey, Victor H Jimenez-Zepeda, Douglas A Stewart, Marta Chesi, Peter Leif Bergsagel, Don Morris
Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model. Blood advances 3 (5) (2020)
Nadine H Abdallah, Sundararajan Vincent Rajkumar, Patricia Greipp, Prashant Kapoor, Morie A Gertz, Angela Dispenzieri, Linda B Baughn, Martha Q Lacy, Suzanne R Hayman, Francis K Buadi, David Dingli, Ronald S Go, Yi L Hwa, Amie Fonder, Miriam Hobbs, Yi Lin, Nelson R Leung, Taxiarchis Kourelis, Rahma Warsame, Mustaqeem A Siddiqui, John Lust, Robert A Kyle, Peter Leif Bergsagel, Rhett Ketterling, Shaji K Kumar
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response. Blood cancer journal 10 (8) (2020)
Luke Mountjoy, Sinto Sebastian, Tania Jain, Talal Hilal, Miguel Gonzalez-Velez, Marlene Girardo, Greg Ahmann, Jeremy Larsen, Peter Leif Bergsagel, Rafael Fonseca
Prediction of immunomodulatory drugs (IMiDs) sensitivity in myeloma via determination of baseline anti-oxidative stress capacity. Leukemia 34 (11) (2020)
Peter Leif Bergsagel, W Michael Kuehl
Promiscuous Structural Variants Drive Myeloma Initiation and Progression. Blood cancer discovery 1 (3) (2020)
Cecilia Bonolo de Campos, Nathalie Meurice, Joachim L Petit, Alysia N Polito, Yuan Xiao Zhu, Panwen Wang, Laura A Bruins, Xuewei Wang, Ilsel D Lopez Armenta, Susie A Darvish, Greg J Ahmann, Kimberly J Henderson, Shulan Tian, Jonas J Kruse, William M Stewart, Jeremy T Larsen, Craig B Reeder, David Dingli, Prashant Kapoor, Shaji K Kumar, Rafael Fonseca, Peter Leif Bergsagel, Esteban Braggio, A Keith Stewart
"Direct to Drug" screening as a precision medicine tool in multiple myeloma. Blood cancer journal 10 (5) (2020)
James Smadbeck, Jess F Peterson, Kathryn E Pearce, Beth A Pitel, Andrea Lebron Figueroa, Michael Timm, Dragan Jevremovic, Min Shi, A Keith Stewart, Esteban Braggio, Daniel L Riggs, Peter Leif Bergsagel, George Vasmatzis, Hutton M Kearney, Nicole L Hoppman, Rhett P Ketterling, Shaji K Kumar, Sundararajan Vincent Rajkumar, Patricia T Greipp, Linda B Baughn
Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma. Blood cancer journal 9 (12) (2019)
Peter Leif Bergsagel, W Michael Kuehl
Detailing the genomic landscape of myeloma. Blood 132 (6) (2019)
Kristine Misund, Niamh Keane, Caleb K Stein, Yan W Asmann, Grady Day, Seth Welsh, Scott A Van Wier, Daniel L Riggs, Greg Ahmann, Marta Chesi, David S Viswanatha, Shaji K Kumar, Angela Dispenzieri, Veronica Gonzalez-Calle, Robert A Kyle, Michael O'Dwyer, S Vincent Rajkumar, K Martin Kortüm, Jonathan J Keats, null null, Rafael Fonseca, A Keith Stewart, W Michael Kuehl, Esteban Braggio, Peter Leif Bergsagel
MYC dysregulation in the progression of multiple myeloma. Leukemia 34 (1) (2019)
Yuan Xiao Zhu, Chang-Xin Shi, Laura A Bruins, Xuewei Wang, Daniel L Riggs, Brooke Porter, Jonathan M Ahmann, Cecilia Bonolo de Campos, Esteban Braggio, Peter Leif Bergsagel, A Keith Stewart
Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4. Blood cancer journal 9 (2) (2019)
Arianna Calcinotto, Arianna Brevi, Marta Chesi, Roberto Ferrarese, Laura Garcia Perez, Matteo Grioni, Shaji K Kumar, Victoria M Garbitt, Meaghen E Sharik, Kimberly J Henderson, Giovanni Tonon, Michio Tomura, Yoshihiro Miwa, Enric Esplugues, Richard A Flavell, Samuel Huber, Filippo Canducci, Vincent S Rajkumar, Peter Leif Bergsagel, Maria Teresa Sabrina Bertilaccio
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression. Nature communications 9 (1) (2018)
Wilson I Gonsalves, Francis K Buadi, Sikander Ailawadhi, Peter Leif Bergsagel, Asher A Chanan Khan, David Dingli, Angela Dispenzieri, Rafael Fonseca, Susan R Hayman, Prashant Kapoor, Taxiarchis V Kourelis, Martha Q Lacy, Jeremy T Larsen, Eli Muchtar, Craig B Reeder, Taimur Sher, A Keith Stewart, Rahma Warsame, Ronald S Go, Robert A Kyle, Nelson R Leung, Yi Lin, John A Lust, Stephen J Russell, Stephen R Zeldenrust, Amie L Fonder, Yi L Hwa, Miriam A Hobbs, Angela A Mayo, William Joseph Hogan, S Vincent Rajkumar, Shaji K Kumar, Morie A Gertz, Vivek Roy
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement. Bone marrow transplantation 54 (3) (2018)
Reeder M Robinson, Leticia Reyes, Ravyn M Duncan, Haiyan Bian, Allen B Reitz, Yefim Manevich, Jesse J McClure, Matthew M Champion, C James Chou, Meahgen E Sharik, Marta Chesi, Peter Leif Bergsagel, Nathan G Dolloff
Inhibitors of the protein disulfide isomerase family for the treatment of multiple myeloma. Leukemia 33 (4) (2018)
Linda B Baughn, Kathryn Pearce, Dirk Larson, Mei-Yin Polley, Eran Elhaik, Michael Baird, Colin Colby, Joanne Benson, Zhuo Li, Yan Asmann, Terry Therneau, James R Cerhan, Celine M Vachon, A Keith Stewart, Peter Leif Bergsagel, Angela Dispenzieri, Shaji K Kumar, S Vincent Rajkumar
Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry. Blood cancer journal 8 (10) (2018)
Tania Jain, Hemalatha Narayanasamy, Joseph Mikhael, Craig B Reeder, Peter Leif Bergsagel, Angela Mayo, A Keith Stewart, Farouk Mookadam, Rafael Fonseca
Systolic dysfunction associated with carfilzomib use in patients with multiple myeloma. Blood cancer journal 7 (12) (2017)
Peter Leif Bergsagel, Marta Chesi
Promiscuous mechanisms underlie the antitumor effects of thalidomide analogs. Nature medicine 22 (7) (2017)
Charlotte Pawlyn, M D Bright, A F Buros, C K Stein, Z Walters, L I Aronson, Fabio Mirabella, J R Jones, M F Kaiser, B A Walker, G H Jackson, P A Clarke, Peter Leif Bergsagel, P Workman, M Chesi, G J Morgan, F E Davies
Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control. Blood cancer journal 7 (3) (2017)
Marta Chesi, Noweeda N Mirza, Victoria M Garbitt, Meaghen E Sharik, Amylou C Dueck, Yan W Asmann, Ilseyar Akhmetzyanova, Heidi E Kosiorek, Arianna Calcinotto, Daniel L Riggs, Niamh Keane, Gregory J Ahmann, Kevin M Morrison, Rafael Fonseca, Martha Q Lacy, David Dingli, Shaji K Kumar, Sikander Ailawadhi, Angela Dispenzieri, Francis Buadi, Morie A Gertz, Craig B Reeder, Yi Lin, Asher A Chanan-Khan, A Keith Stewart, David Fooksman, Peter Leif Bergsagel
IAP antagonists induce anti-tumor immunity in multiple myeloma. Nature medicine 22 (12) (2016)